Patient demand for spectacle independence is growing. The advances in laser and non-laser technology have allowed ophthalmologists to offer their patients the freedom to choose between depending on their glasses, or to go spectacle free. Presbyopia, defined as the age-related loss of the ability to clearly accommodate onto near objects, has become the last frontier for refractive vision correction.
US Ophthalmic Review
Early inlays were composed of flint glass and plexiglass for the correction of aphakia and high myopia. Earlier trials attempted to use poly(methyl methacrylate) (PMMA) and polysulfone inlays to treat high myopia. 11 High index polymers were an optically attractive material choice; however, poor permeability limited their use. As a result, Barraquer developed human donor stromal lenticules for inlays (keratophakia) and onlays (epikeratophakia). Claes H. Dohlman was the first to describe the use of a permeable lenticule in 1967. 12 Hydrogel inlays were developed so as not to impede metabolic gradients across the stroma including nutrient flow to the anterior cornea. Although semipermeable hydrogel polymers allow free nutrient flow, they have a relatively low index of refraction and are therefore limited in optical power.
Past inlay designs include the Kerato-Gel™ (Allergan, Inc., Irvine, California), which was designed for aphakia and was composed of lidofilcon A. The Chiron inlay ® (Bausch & Lomb, Rochester, New York) was a meniscus hydrogel optical lens that ranged from 1.50 to 3.50 diopter (D) in add power with a diameter ranging from 1.8 to 2.2 mm. The PermaVision Intracorneal Lens ® (Anamed, Lake Forest, California) was composed of a hydgrogel-based material called Nutrapore with a water content of 78 %.
This lens, measuring 5.0 to 5.5 mm in diameter with a central thickness of 30 to 60 μm, intentionally altered the anterior surface curvature. This was followed by the IntraLens (now ReVision Optics ® , Inc., Lake Forest, California) in the evolution of space-occupying lenticules that intentionally altered the surface curvature to create a kind of multifocal cornea for the treatment of hyperopia and presbyopia. These technologies served as the precursor for the Raindrop inlay (formerly the Vue+ and PresbyLens, ReVision Optics, Inc.). The Intracorneal Microlens™ (BioVision AG, Brüggs, Switzerland) was a 3 mm diameter, 20 μm thick hydrogel annular add inlay with a central opening free of optical power that also allowed nutrient flow to the anterior central cornea. This inlay was designed for placement in a stromal pocket with a mechanical microkeratome pocket maker.
The Microlens went on to be known as the InVue™, the precursor to the Flexivue inlay™ (Presbia Coöperatief U.A., Amsterdam, the Netherlands).
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The Problem with Corneal Inlays
In order for the cornea to function properly its distinct traits must be maintained. The cornea must remain transparent in order for light rays to enter the eye. This transparency is achieved because of the avascular structure of the cornea, the scarcity of cells within its stroma, its unmyelinated nerve fibers, its relative state of dehydration, and, most
importantly, the precise arrangement of its collagen fibrils. Corneal stromal fibrils have a characteristically narrow diameter and are aligned in parallel arrays and immersed in specialized clusters of proteoglycans.
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The corneal stroma undergoes homeostatic remodeling via the functions performed by keratocytes and possibly other cell types, including bone marrow-derived cells and myofibroblasts. Keratocytes are responsible for the production and maintenance of the extracellular matrix of the corneal stroma. 17 Changes in environmental conditions, such as an intrastromal implant, may modulate the keratocyte phenotype, resulting in functional changes in gene expression, contractility, matrix production, and other characteristics that contribute to the wound-healing response.
Therefore, the goal of successful inlay design, implantation technique, and perioperative care is to minimize or eliminate the potential changes induced by the introduction of this foreign material into the cornea. 18 The cornea, besides being an avascular structure, is also considered a very special tissue because of how it receives both its oxygen and nutrients indirectly by diffusion either from the aqueous humor posteriorly or from the pre-corneal tear film anteriorly. Any insult to the cornea that significantly affects those distinctive properties will interfere with its function with subsequent affect vision. [18] [19] [20] Inlays should be semipermeable, allowing oxygen supplied from the tear film and glucose supplied from the aqueous humor to nourish the vital corneal cells while also allowing catabolic end products to be delivered to the aqueous humor. This mechanism is essential to prevent anterior stromal necrosis and corneal edema, which plagued older attempts at placing an inlay within the corneal stroma. 13 This problem with older inlay models was clearly demonstrated by
Mulet and his co-workers where 34 hyperopic eyes were implanted with a hydrogel intra-corneal inlay (PermaVision ® ) where they came to a conclusion that intra-corneal inlays was a good option for treating hyperopia, but that the tested inlay caused significant visual loss and scarring and had to be explanted in the majority of cases. 21 Another practical problem that all commercially available inlays share is that they rely entirely on pupillary size. Even though all three inlays aim to reduce presbyopia symptoms through very different mechanisms, they all work through improving the image formed through the narrowed pupil. Therefore as soon as the pupil becomes larger than the outer diameter of each inlay, the effect of improving unaided near vision decreases dramatically.
Mechanism of Action of Modern Corneal Inlays
The three modern corneal inlays that are being investigated and used 
The Kamra Inlay
The near synkinesis is composed of accommodation, convergence, and miosis. It has been proved that narrowing of the pupillary aperture improves depth of focus and aids in improving near vision even when accommodation is kept constant. The Kamra Inlay (previously known as the ACI 7000) utilizes the latter part of this synkinesis in an attempt to improve near vision in presbyopes. 20 The KAMRA Inlay is a 10.0 μm thin microperforated artificial aperture, with The inlay is inserted via a special injector in a corneal pocket created using a femtosecond laser to a depth of approximately 280-300 mm with a diameter of 9.0 mm. The inlay is centered onto the line of sight using the microscope and centration device of the microscope (see Figure 4 ). 
The Raindrop
The Raindrop corneal inlay is made of a clear, permeable hydrogel material that has the same refractive index as the cornea (1.376).
The inlay has a positive meniscus shape, with a diameter of 2 mm and a central thickness of 32 µm. The inlay has no intrinsic refractive power because it has the same refractive index of the surrounding corneal tissue (see Figure 5 ). The inlay works through altering the refractive power of the eyes by increasing the central radius of curvature of the cornea directly overlying the implant. The inlay is thinner at the edge than at the center, allowing for a smooth transition in the corneal anterior radius of curvature from the area directly overlying the inlay, to the mid-zone then finally to the unaltered peripheral cornea. The permeability of the hydrogel material used to manufacture this inlay insures free passage of oxygen and nutrients across it, thus preventing unwanted side effects such as stromal and epithelial edema. Table 1 ).
The second paper by Garza et Table 2 ). Also, visual symptoms (glare, halos, blurred vision, double vision, and fluctuation in vision) were analyzed using a scale. At 12 months, none of the 36 patients involved in both studies reported any increase in subjective experience of such phenomenon, while performance of the visual tasks had clearly improved.
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Conclusion
Intracorneal inlay implantation has become a topic of great interest to ophthalmologists. Not only have studies shown their efficiency in treating presbyopia, but also the extra-ocular nature of the procedure, ease of insertion, and potential for reversibility make the latest commercially available models very appealing. 
